Our Focus: Serving Patients

EOM is focused on helping better the quality of life for people with debilitating and potentially fatal diseases. We are developing first-in-class treatments to restore health and save lives. EOM’s pipeline of proprietary innovations may address the most dire pathological effects of COVID-19 as well as meet therapeutic challenges associated with other infectious disease; autoimmune diseases including rheumatoid arthritis; cachexia associated with AIDS and cancer; and blinding retinal diseases.

Severe Effects of Infectious Disease, Including COVID-19

Severe Effects of Infectious Disease, Including COVID-19

COVID-19 is a highly infectious and potentially fatal disease, causing over 2 million deaths and more than 99 million cases worldwide.1

Chemokine-Related Body Wasting  Syndromes: Cancer Cachexia

Chemokine-Related Body Wasting Syndromes: Cancer Cachexia

Cachexia, also called cancer cachexia or cancer anorexia cachexia, is a wasting syndrome. It is the loss of fat and muscle due to a chronic disease, such as cancer, and not eating enough nutrients (malnourishment). Cachexia causes weight loss, loss of appetite, weakness and fatigue.2

Cancer cachexia is caused by a combination of decreased nutritional intake and altered metabolism and is defined as ongoing loss of skeletal muscle mass that cannot be reversed by conventional nutritional support. It is characterized by progressive functional impairment and contributes to more than 20% of cancer deaths. Since around 50% of patients with malignant disease cannot be cured and more than 80% of advanced cancer patients experience cachexia, the toll of this condition is severe both for society and the individual patient.3

The prevalence of cachexia is as high as 87% in patients with pancreatic and gastric cancer, 61% in patients with colon, lung, and prostate cancer and non-Hodgkin lymphoma, and 40% in breast cancer, sarcoma, leukemia, and Hodgkin lymphoma.4

Autoimmune Diseases: Rheumatoid Arthritis

Autoimmune Diseases: Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a debilitating chronic autoimmune disease that affects the joints, connective tissues, muscle, tendons, and fibrous tissue, and causes pain and deformity.

The World Health Organization estimates more than 23 million people, mostly women, live with RA.5

Retinal Diseases

Retinal Diseases

Retinal diseases, including AMD and diabetic retinopathies, affect the vital tissue of the eye and can lead to blindness.

Age-Related Macular Degeneration (AMD)

Age-related macular degeneration (AMD) is an eye disease that can blur the sharp, central vision you need for activities like reading and driving. “Age-related” means that it often happens in older people. “Macular” means it affects a part of your eye called the macula. AMD is a common condition — it’s a leading cause of vision loss for people age 50 and older. AMD doesn’t cause complete blindness but losing your central vision can make it harder to see faces, drive, or do close-up work like cooking or fixing things around the house.6

By 2050, the estimated number of people with AMD in the U.S. is expected to more than double from 2.07 million to 5.44 million.7 The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.8

Diabetic Retinopathy (DR):

Diabetes is the leading cause of new cases of blindness in adults. About 1 in 3 people with diabetes have Diabetic Retinopathy, affecting almost one-third of adults over age 40 years with diabetes, and more than one-third of African Americans and Mexican Americans.9

Diabetic retinopathy affects 7.7 million Americans, and that number is projected to increase to more than 14.6 million people by 2030.10